PORTHOS
Funding Entity AstraZeneca
Financed Amount 450.000,00€
Objective
The PORTHOS study was developed with the aim of knowing the number of people (prevalence) who suffer from heart failure in Portugal.
It is an essential study to characterize the population suffering from this disease and to help plan care organization strategies and health policies.
The participation of all those who were invited is very important, as only then will we be able to understand the reality of heart failure in our country and improve health care for people who suffer from this disease.